Header Logo
Newsletter Podcast
Log In
← Back to all posts

Lasting Relief, Better Outcomes—Plus What PRP Docs Are Doing Differently

Apr 29, 2025
Connect

Highlights

  • Today’s Research Article: Your go-to treatment just got outperformed—see why PRP is leading in joint relief.

  • Questions from the Field: Even if they’re under 65, it’s better to have the ABN signed—every time.

  • Let’s Get Down to Business: Educate, personalize, and document—keys to building a thriving PRP practice.

  • Come Join Us: Train smarter, connect deeper—your next breakthrough starts at a live event.

If this newsletter was forwarded to you and you'd like to receive future updates directly, subscribe here.


Today’s Research Article

Platelet-Rich Plasma versus Corticosteroid Intra-Articular Injections for the Treatment of Trapeziometacarpal Arthritis: A Prospective Randomized Controlled Clinical Trial

Michael-Alexander Malahias, Leonidas Roumeliotis, Vasileios S. Nikolaou, Efstathios Chronopoulos, Ioannis Sourlas, and Georgios C. Babis

Read the full article here.

Summary:

This prospective randomized controlled trial by Malahias et al. compared intra-articular platelet-rich plasma (IA-PRP) injections with corticosteroid injections for treating early to moderate trapeziometacarpal (thumb base) arthritis. Over 12 months, patients receiving IA-PRP experienced significantly better outcomes in pain relief (VAS score), hand function (Q-DASH score), and satisfaction than those treated with corticosteroids. While both treatments showed improvement at 3 months, only the PRP group maintained and improved these benefits at 12 months, with 62.5% of PRP patients reporting mild pain vs. just 12.5% in the steroid group.

The study also demonstrated that patient satisfaction with PRP rose over time, reaching 69% at 12 months compared to only 12.5% in the steroid group. This sustained improvement is attributed to PRP’s biological effects, including anti-inflammatory properties and stimulation of cartilage repair. Given its longer-lasting relief and functional improvement, IA-PRP offers a superior non-surgical option for managing mild to moderate thumb arthritis compared to the short-lived effects of corticosteroids.

Doctor-to-Patient Talking Points for Choosing IA-PRP Over Steroids (with Evidence)

Subscribe to keep reading this post

Subscribe

Already have an account? Log in

Loading...
Evidence, Earnings, Elevation: PRP Outcomes, Pricing & Events
Highlights Today’s Research Article: Early OA? One injection of PRP or HA helps—PRP moves the needle faster.   Questions from the Field: If you measure it, you can price it—structure PRP fees around proven value.   Let’s Get Down to Business: Reclaim your practice—innovate clinically, communicate publicly, mentor boldly.   Come Join Us - Your October sprint: TrueMD Live → ICRS → Apex L...
PRP Research. Real-World Tips. All Roads Lead to TrueMD Live
Highlights Today’s Research Article: PRP beats steroids & PT in SAIS: more pain relief, better function, better QoL at 8 weeks. Questions from the Field: Short-axis halo first, then long-axis—radial or ulnar entry both safe in the median-ulnar “safe zone.” Let’s Get Down to Business: Pick one vivid patient avatar to attract the right clients—and stop saying yes to the wrong ones. Come ...
PRP Evidence, Branding for Doctors & Join Us Live Sept 18
Highlights Today’s Research Article: PRP halved knee-OA pain and boosted function at 6 months—double-blind, same-patient control. Questions from the Field: Yes—drain the effusion, then PRP same day to avoid dilution and clear catabolic enzymes. Let’s Get Down to Business: Patients choose connection over credentials—your personal brand is the clinical edge. Come Join Us: Live PRP demo +...

The OBX Brief

Your guide to Orthobiologics Literature
Footer Logo
Newsletter Podcast
© 2025 Kajabi
Powered by Kajabi

Join Our Free Trial

Get started today before this once in a lifetime opportunity expires.